Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 442 Rectal Neoplasms 209 Colonic Neoplasms 202 Pancreatic Neoplasms 133 Stomach Neoplasms 117 Neoplasm Metastasis 97 Neoplasms 64 Esophageal Neoplasms 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Lymphoma 49 Leukemia 41 Carcinoma, Hepatocellular 41 Adenocarcinoma Of Esophagus 37 Burkitt Lymphoma 33 Adenocarcinoma 29 Cholangiocarcinoma 27 Biliary Tract Neoplasms 23 Carcinoma, Non-Small-Cell Lung 21 Gastrointestinal Neoplasms 20 Gallbladder Neoplasms 20 Lymphoma, Non-Hodgkin 19 Esophageal Squamous Cell Carcinoma 15 Osteosarcoma 14 Liver Neoplasms 14 Bile Duct Neoplasms 14 Unspecified Adult Solid Tumor, Protocol Specific 13 Lymphoma, Large B-Cell, Diffuse 13 Leukemia, Biphenotypic, Acute 13 Ovarian Neoplasms 12 Leukemia, Myeloid, Acute 12

Interventions

atezolizumab 2 Paclitaxel 2 Nivolumab 2 Immunoglobulin G 2 Disulfides 2 Bevacizumab 2 irinotecan sucrosofate 1 cobimetinib 1 Taxes 1 Specimen Handling 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Famotidine 1 Docetaxel 1 Diphenhydramine 1 Dexamethasone 1 DNA Fingerprinting 1 Chemoradiotherapy 1 Carboplatin 1 Calcium Dobesilate 1 CTLA-4 Antigen 1 Bromelains 1 Axitinib 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma, Mucinous × Leucovorin × Clear all

NCT05504252 2026-01-07

METIMMOX-2

University Hospital, Akershus

Phase 2 Active not recruiting

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡